Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2018-07-17
2020-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB)
NCT07344961
Substrate Ablation Guided by High Density Mapping in Atrial Fibrillation
NCT02093949
STrategies for Catheter Ablation of peRsistent Atrial Fibrlllation
NCT04428944
ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization
NCT03370536
Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation
NCT01505296
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
the intraoperative effectiveness of the AIFIB software in real time in the detection of atrial fibrillation drivers during an ablation procedure.
Real-time validation by an expert operator of the correct detection of atrial fibrillation driver
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Etiology in the following list:
* Atrial fibrillation for which a conventional anatomical approach alone (pulmonary vein isolation) is not performed: persistent AF, long standing persistent AF paroxysmal AF (redo), paroxysmal AF
* Atrial tachycardia de novo or secondary to AF ablation.
Exclusion Criteria
* Major bleeding disorder
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital St. Joseph, Marseille, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Groupe Hopitaux Institut Catholique de Lille
Lille, , France
Clinique de l'Infirmerie Protestante
Lyon, , France
Saint Joseph Hospital
Marseille, , France
Clinique Ambroise Paré, Neuilly
Neuilly-sur-Seine, , France
CHU NICE Pasteur
Nice, , France
IHCPS Massy
Paris, , France
Centre de cardiologie du Nord
Saint-Denis, , France
Clinique Pasteur
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSJ_EvAIFIB_2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.